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Abstract
A series of substituted diaryltriazoles was prepared by a solid-phase-synthesis protocol using a modified Wang resin. The copper(I)-
or ruthenium(II)-catalyzed 1,3-cycloaddition on the polymer bead allowed a rapid synthesis of the target compounds in a parallel
fashion with in many cases good to excellent yields. Substituted diaryltriazoles resemble a molecular structure similar to estab-
lished terphenyl-alpha-helix peptide mimics and have therefore the potential to act as selective inhibitors for protein–protein inter-
actions.
Introduction
The α-helix was the first-described secondary structure of
peptides discovered by Linus Pauling in 1951 [1]. With about
30% of the amino acids in proteins being part of α-helices [2], it
is the most common secondary structure found in proteins [3].
Protein–protein as well as protein–DNA and protein–RNA
interactions often involve α-helices as recognition motifs on
protein surfaces [4]. These helices are important targets for new
drugs, but stabilization of the helix folding for small structures
with less than 15 residues still remains a challenge [5,6]. Thus,
new attempts have been made to design low-molecular-weight
ligands that disrupt protein–protein interactions [7]. For
example, fast proteolytic degradation observed with small
peptide-based compounds [8], can be overcome by compounds
stabilized by non-natural amino acids [9] or cross-linked
between side chains and the backbone [10]. Replacement of the
complete backbone by a nonpeptidic scaffold, which positions
side chains in the typical i, i+3 and i+7 arrangement of an
α-helix is another successful strategy [11]. Horwell pioneered
this type of peptidomimetics and showed that 1,6-disubstituted
indanes can imitate the helix residues i and i+1 [12,13].
Hamilton reported a 3,2′,2″-substituted terphenyl scaffold with
a spatial orientation that mimics the i, i+3 and i+7 moieties on
the surface of an α-helical peptide [14]. Inspired by the
terphenyl-based α-helix mimetics 1, several related compounds
Beilstein J. Org. Chem. 2012, 8, 1027–1036.
1028
Scheme 2: Synthesis of azido-functionalized resins 7 and 9.
Scheme 1: Terphenyl scaffold 1 [13,14]; oxazole-pyridazine-piper-
azine 2 [14,15] and aryl-triazoles 3 and 4 [15,16] as α-helix mimetics.
containing three or more adjacent aryl rings (Scheme 1), such as
2, were reported [15]. However, the synthesis of substituted
triaryl compounds can be tedious, and the predictability of their
potency and selectivity as inhibitors is still limited. We have
recently reported the synthesis of triazole-based α-helix
mimetics 3 and 4 [16], which are efficiently available through
azide–alkyne cycloadditions [17]. We now report the use of this
chemistry to prepare libraries of potential inhibitors of
protein–protein interactions.
Results and Discussion
Synthesis of azide-functionalized Wang
resins
Two azide-functionalized resins were prepared for the solid-
phase synthesis of diaryl-triazoles. The commercially
available 4-(bromomethyl)benzoic acid (5) was converted into
azide 6 in anhydrous DMF with sodium azide under
heating. Coupling to Wang resin in dichloromethane, by using
DIC and DMAP as coupling reagents, gave resin 7 in quantitat-
ive yield (Scheme 2) [18]. Commercially available 4-azidoben-
zoic acid (8) gave resin 9 in an analogous esterification of a
Wang resin.
Solid-phase synthesis of diaryltriazoles
The conditions for the solid-phase synthesis of diaryltriazoles
on functionalized Wang resin 7 were optimized by using five
different alkynes 10a–e, containing acyclic or cyclic aliphatic
moieties, simple arenes and 1-(but-3-yn-2-yl)-3-(4-chloro-
phenyl)-1-methylurea (10c) as an example of a more complex
alkyne. The azide–alkyne [3 + 2] cycloaddition was catalyzed
with copper(II) sulfate pentahydrate and L-ascorbic acid in
DMF overnight at room temperature. A solution of EDTA was
added to remove the remaining copper cations from the resin.
Resin cleavage under acidic conditions with TFA in DCM gave
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Table 1: Copper-catalyzed [2 + 3] cycloadditions of resin-bound azide 7 with five terminal alkynes.
terminal alkyne 10 product 11 yield [%]
10a
11a
63
10b
11b
90
10c
11c
81
10d
11d
57
10e 11e
71
compounds 11a–e in moderate to excellent overall yields of
57 to 90% (Table 1). Due to the solid phase synthesis protocol
the crude material purity was typically high, ranging from 70 to
90%. Alkyne 10d and 10e bearing hydroxy groups were
converted quantitatively, but elimination of water occurred in
the presence of TFA. The dehydrated products were obtained in
57 and 71%. The remaining material was the corresponding
hydroxylated product.
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Table 2: Copper-catalyzed [2 + 3] cycloadditions of resin bound azide 7 with five terminal alkynes. Compounds 13, with the exception of 13f, were
only characterized during compound library synthesis, by HPLC–MS analysis.
alkyne 10 product after cleavage from resin (yield)
reaction 1
resin 7, catalyst CuSO4
reaction 2
resin 9,
catalyst CuSO4
reaction 3
resin 7, catalyst Cp·RuCl(PPh3)2
10f 11f (95%)
12a (49%)
13a not obtained
Parallel synthesis of a compound library
A larger compound library was prepared by using resins 7 and
9, 15 different terminal alkynes 10f–t and either copper or
ruthenium-catalyzed [2 + 3] cycloadditions. The three reactions
and the obtained products 11 (reaction 1), 12 (reaction 2) and 13
(reaction 3) are summarized in Table 2.
Reaction 1 follows the established protocol and, gave after
removal of the copper salts with a solution of EDTA and TFA
cleavage, the corresponding products in good to quantitative
yields (88–99%). Resin 9 was used in reaction 2 under other-
wise identical reaction conditions. The use of an aromatic azide
leads to more rigid products containing three adjacent aromatic
rings: The central triazole and the phenyl ring of the benzoic
acid as constant structural elements and the third ring consisting
either of substituted benzenes, heteroarenes or a polycyclic
aromatic compound. Lower product yields were obtained in this
series of compounds, ranging from 21 to 63%. The lower re-
activity of the aromatic azide and the increased steric demand
may explain the decrease in yield in comparison to that of the
Beilstein J. Org. Chem. 2012, 8, 1027–1036.
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Table 2: Copper-catalyzed [2 + 3] cycloadditions of resin bound azide 7 with five terminal alkynes. Compounds 13, with the exception of 13f, were
only characterized during compound library synthesis, by HPLC–MS analysis. (continued)
10g
11g (99%)
12b (44%)
13b (43%)
10h
11h (97%)
12c (45%)
13c (89%)
10i
11i (98%)
12d (44%)
13d (89%)
10j
11j (98%)
12e (41%)
13e (90%)
10k
11k (97%)
12f (21%)
13f (48%)
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Table 2: Copper-catalyzed [2 + 3] cycloadditions of resin bound azide 7 with five terminal alkynes. Compounds 13, with the exception of 13f, were
only characterized during compound library synthesis, by HPLC–MS analysis. (continued)
10l
11l (98%)
12g (52%)
13g (94%)
10m
11m (88%)
12h (38%)
13h (96%)
10n
11n (98%)
12i (41%)
13i (80%)
10o
11o (97%)
12j (63%)
13j (82%)
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Table 2: Copper-catalyzed [2 + 3] cycloadditions of resin bound azide 7 with five terminal alkynes. Compounds 13, with the exception of 13f, were
only characterized during compound library synthesis, by HPLC–MS analysis. (continued)
10p
11p (99%)
12k (47%)
13k (89%)
10q
11q (98%)
12l (40%)
13l (89%)
10r
11r (98%)
12m (61%)
13m (92%)
10s
11s (94%)
12n (26%)
13n (95%)
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Table 2: Copper-catalyzed [2 + 3] cycloadditions of resin bound azide 7 with five terminal alkynes. Compounds 13, with the exception of 13f, were
only characterized during compound library synthesis, by HPLC–MS analysis. (continued)
10t
11t (96%) 12o not obtained
13o (74%)
former series of compounds. The formation of the compound
12o, bearing a particularly bulky substituent, was not observed.
Replacing the copper(I) catalyst by a ruthenium(II) complex
allows the preparation of regioisomers in reaction 3. Instead
of the 1,4-disubstituted triazoles obtained from copper(I) catal-
ysis, the complex pentamethylcyclopentadienylbis(tri-
phenylphosphine)ruthenium(II) chloride leads to 1,5-disubsti-
tuted triazole compounds [19]. 4-(Azidomethyl)benzoic acid
functionalized Wang resin 7 and the alkynes 10f–t were reacted
in DMF at 70 °C overnight, and the products 13b–o were
obtained after TFA cleavage from the resin in moderate to good
yields ranging from 43–96%. Only compound 13a could not be
obtained. The proton NMR analysis allows us to clearly distin-
guish between 1,4- and 1,5-disubstituted triazoles due to a char-
acteristic shift of the triazole proton resonance. The triazole
proton of the 1,4-disubstituted ring in compound 11k shows a
1H NMR resonance at δ = 8.71 (400 MHz, DMSO-d6), while
the resonance signal for the triazole proton of product 13f is
observed at δ = 8.00 (400 MHz, DMSO-d6). Compounds 13,
with the exception of compound 13f, were only characterized
by mass spectrometry during the synthesis of the compound
library.
The copper-mediated [2 + 3] cycloadditions are restricted to
terminal alkynes. However, the ruthenium-catalysis allows
the use of internal alkynes. In preliminary work, resin 7 was
therefore reacted with internal alkynes 14a–c and pentamethyl-
cyclopentadienylbis(triphenylphosphine)ruthenium(II) chloride
as catalyst in DMF at 70 °C overnight followed by TFA
cleavage [20]. LC–MS analysis of the crude product revealed
the formation of compounds 15a–c in high yields of 78–98%
(Table 3).
Conclusion
Diaryltriazoles were obtained in an efficient three-step solid-
phase procedure. Immobilization of aromatic azides on
Table 3: Ruthenium-catalyzed [2 + 3] cycloadditions of resin-bound
azide 7 with three disubstituted alkynes.
alkyne product 15 (yield)a
14a
15a (78%)
14b
15b (84%)
14c
15c (98%)
aYields based on LC–MS; compound 12b was used as standard.
Beilstein J. Org. Chem. 2012, 8, 1027–1036.
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commercial  Wang resin fol lowed by copper(I)-  or
ruthenium(II)-catalyzed 1,3-cycloaddition and subsequent
cleavage of the product from the resin gave the target structures
in good to excellent yields with the possibility to introduce a
wide variety of different substituents. The alternative use of
copper or ruthenium catalysis for the on-bead cycloaddition
gives regioisomeric products, which extends the diversity of the
compound collection. The method may find application in the
combinatorial search for selective protein–protein inhibitors. To
that end, most of the compounds prepared herein were
submitted to the Molecular Libraries Small Molecular Reposi-
tory for ongoing inclusion in high-throughput screening activi-
ties.
Experimental
General procedures
GP 1 – Coupling of benzoic acid derivatives 6 and 8 on
Wang resin: Wang resin (1 equiv) was preswollen in
dichloromethane (0.8 mL/100 mg resin) for 2 h at room
temperature. Subsequently, both coupling reagents N,N′-diiso-
propylcarbodiimide (3.5 equiv) and dimethylaminopyridine
(0.5 equiv) were added. After the addition of the benzoic acid
derivative 6 or 8 (2.5 equiv) the reaction mixture was stirred for
20 h at room temperature. The resin was first washed with
dimethylformamide, methanol and dichloromethane (each
solvent 3 × 0.8 mL/100 mg resin), and then dried in high
vacuum for 3 h.
GP 2 – Huisgen 1,3-dipolar cycloaddition of solid-phase-
immobilized azides with terminal alkynes by copper(I)
catalysis: An azide-functionalized Wang resin 7 or 9 (1 equiv)
was preswollen in dimethylformamide (1.5 mL/100 mg resin)
for 2 h at room temperature. The copper(I) catalyst was
prepared in situ by using L-ascorbic acid (0.5 equiv) as
reducing agent and copper(II) sulfate pentahydrate (10 mol %).
After the terminal alkyne (4 equiv) was added, the reaction mix-
ture was stirred for 22 h at room temperature. The resin was
w a s h e d  w i t h  d i m e t h y l f o r m a m i d e ,  m e t h a n o l  a n d
dichloromethane (each solvent 2 mL/100 mg resin). The
remaining copper cations were complexed and removed by
using a solution of ethylenediaminetetraacetic acid disodium
salt. For this purpose, a 1:1 mixture of dimethylformamide and
disodium EDTA (aq., sat.) was added to the resin and stirred for
10 min at room temperature. Again washing steps with water,
dimethylformamide, methanol and dichloromethane (each
solvent 3 × 2 mL/100 mg resin) were carried out.
GP 3 – Huisgen 1,3-dipolar cycloaddition of solid-phase-
immobilized azides with terminal or internal alkynes by
ruthenium(II) catalysis: The azide functionalized Wang resin
(1 equiv) was preswollen in dimethylformamide (2 mL/100 mg
resin) for 2 h at room temperature. Subsequently, the catalyst
complex pentamethylcyclopentadienylbis(triphenylphos-
phine)ruthenium(II) chloride, Cp·RuCl(PPh3)2, (5 mol %) and
either a terminal or an internal alkyne (4 equiv) were added.
After the reaction mixture was stirred for 22 h at 70 °C, the
resin was washed with dimethylformamide, methanol and
dichloromethane (each solvent 3 × 2 mL/100 mg resin).
GP 4 – Cleavage of solid-phase resin-bound molecules with
TFA: The swollen resin was treated with a 1:4 mixture of tri-
fluoroacetic acid and dichloromethane (1 mL/100 mg resin).
After being stirred for 10 min at room temperature, the cleaved
product was rinsed out of the resin using dichloromethane
(1.5 mL/100 mg resin). The resin was treated once more with
the 20% trifluoroacetic acid solution (1 mL/100 mg resin),
stirred for 10 min at room temperature and washed with
dichloromethane (3 × 1 mL/100 mg resin). The solvent was
evaporated and the product was dried in high vacuum for 4 h.
4-(Azidomethyl)benzoic acid (6) [21]: The synthetic proce-
dure leading to this literature-known compound was improved.
4-(Bromomethyl)benzoic acid (5, 1.2 g, 5.58 mmol, 1.0 equiv)
and sodium azide (907 mg, 13.95 mmol, 2.5 equiv) were
suspended in 25 mL of anhydrous dimethylformamide under a
nitrogen atmosphere. After the reaction mixture was stirred for
15 h at 50 °C the solvent was evaporated. The colorless residue
was dissolved in 90 mL of water and the solution was treated
with 17 mL of hydrochloric acid (c 1 mol/L). The precipitate
was separated with a Büchner funnel,  dissolved in
dichloromethane and dried over potassium sulfate. After filtra-
tion, and evaporation of the solvent, 4-(azidomethyl)benzoic
acid (6, 880 mg, 4.97 mmol, 89%) was yielded as a colorless
solid and dried in high vacuum overnight; mp 135.6–136.6 °C;
1H NMR (300 MHz, CDCl3) δ 4.46 (s, 2 H, H-6), 7.44 (d, 
3JHH
= 8.4 Hz, 2H, H-4), 8.14 (d, 3JHH = 8.3 Hz, 2H, H-3); 
13C
NMR (75 MHz, CDCl3) δ 54.3 (−, 1C, C-6), 128.0 (+, 2C, C-4),
129.1 (Cq, 1C, C-2), 130.8 (+, 2C, C-3), 141.5 (Cq, 1 C, C-5),
171.4 (Cq, 1C, C-1); IR (cm
−1) : 2933 (w), 2880 (w), 2817
(w), 2656 (w), 2110 (m), 2086 (m), 1950 (w), 1682 (s), 1293
(s), 1239 (s), 707 (s), 545 (s); EIMS m/z: 177.0 (40) [M]+, 148.0
(80) [M − N2]
+, 135.0 (100) [M − N3]
+; Anal. calcd for
C8H7N3O2: C, 54.24; H, 3.98; N, 23.72; found: C, 54.28; H,
4.25; N, 23.75.
Supporting Information
Supporting Information File 1
Experimental details and spectra.
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